Observational studyWorld journal of gastroenterology2023

Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real world.

Hong-Chi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.